Outcome of surgery for pancreatic neuroendocrine neoplasms. (scientific article published on 13 August 2014)

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors

Q34248466

Everolimus for advanced pancreatic neuroendocrine tumors.

Q34399809

Rare functioning pancreatic endocrine tumors

Q36741124

Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005.

Q36793415

Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes

Q36943954

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

Q37195528

The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors

Q37832970

Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin

Q37850226

Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management

Q38055926

Everolimus in the treatment of patients with advanced pancreatic neuroendocrine tumors: latest findings and interpretations

Q42576027

Value of both WHO and TNM classification systems for patients with pancreatic endocrine tumors: results of a single-center series

Q44268970

Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors

Q44586452

Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors

Q44824798

Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours

Q44991120

A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress

Q45189937

Neuroendocrine tumor epidemiology: contrasting Norway and North America.

Q46944550

TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.

Q47867776

Discrepancies between two alternative staging systems (European Neuroendocrine Tumor Society 2006 and American Joint Committee on Cancer/Union for International Cancer Control 2010) of neuroendocrine neoplasms of the pancreas. A study of 50 cases.

Q53158169

[Neuroendocrine tumors of the duodenum and pancreas. Surgical strategy].

Q53220408

Pancreatic Endocrine Tumors

Q55981791

Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor

Q57425750

Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas

Q57767637

P433

issue

P407

language of work or name

English

Q1860

P304

page(s)

1405-1412

P577

publication date

2014-08-13

P1433

published in

British Journal of Surgery

Q4970212

P1476

title

Outcome of surgery for pancreatic neuroendocrine neoplasms.

P478

volume

101

Reverse relations

cites work (P2860)

Q33684746	Clinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in China
Q50355400	Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology
Q64088607	Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article
Q37347947	Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective
Q41143330	Impact of Snail and E-cadherin expression in pancreatic neuroendocrine tumors
Q45902785	Lymph node ratio, but not the total number of examined lymph nodes or lymph node metastasis, is a predictor of overall survival for pancreatic neuroendocrine neoplasms after surgical resection.
Q64048620	Macroscopic morphology for estimation of malignant potential in pancreatic neuroendocrine neoplasm
Q37346170	Minichromosome Maintenance Expression Defines Slow-Growing Gastroenteropancreatic Neuroendocrine Neoplasms
Q33779718	Minimally invasive distal pancreatectomy for PNETs: laparoscopic or robotic approach?
Q36194989	Overestimated Oncologic Significance of Lymph Node Metastasis in G1 Nonfunctioning Neuroendocrine Tumor in the Left Side of the Pancreas
Q36680840	Pancreatic Aetiology for Massive Upper Gastrointestinal Haemorrhage in Pregnancy
Q56917284	Pancreatic neuroendocrine tumors
Q38777613	Pathology and Surgical Treatment of High-Grade Pancreatic Neuroendocrine Carcinoma: an Evolving Landscape.
Q36558826	Postoperative Outcomes of Enucleation and Standard Resections in Patients with a Pancreatic Neuroendocrine Tumor
Q38996135	Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience.
Q47432213	Significance of lymph node metastasis in pancreatic neuroendocrine tumor
Q38691825	Sporadic Small (≤20 mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis
Q40200855	Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study.
Q53415537	Surgical resection of neuroendocrine tumors of the pancreas (pNETs) by minimally invasive surgery: the laparoscopic approach.
Q55100026	Surgical resection of pancreatic neuroendocrine neoplasm by minimally invasive surgery-the robotic approach?
Q64068399	Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma
Q36154116	Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms
Q93107212	Time-trend and recurrence analysis of pancreatic neuroendocrine tumors
Q47150030	Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours.